Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophagesDa‐Liang Ou, Chiun Hsu|Journal for ImmunoTherapy of Cancer|2021Cited by 144
Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 SuppressionChiun Hsu, Da‐Liang Ou|Clinical Cancer Research|2015Cited by 49
Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivinDa‐Liang Ou, Ann‐Lii Cheng|Molecular Cancer|2014Cited by 46